-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-iv-nv-hap-protocol.pdf
August 05, 2024 - How could interventions to prevent NV-HAP for inpatients prevent or mitigate
harms?
2. … The purpose of this rapid review is to evaluate and synthesize the evidence on benefits
4
and harms … We will also identify
and describe how these PSPs (a) may prevent or mitigate harms to patients; (b … • Length of stay (hospital and ICU)
• Mortality
• NV-HAP related rehospitalization
• Unintended harms … details about the outcomes (e.g., definitions, incidence,
prevalence, timing, severity), unintended harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/blood-clots-hip-knee-surgery_surveillance.pdf
December 01, 2012 - As such, it is likely inferior to factor
Xa inhibitors in the balance of benefits and harms
as well … The balance of benefits and harms from using
enoxaparin versus another low molecular weight
heparin … Harms were not
assessed in these trials or observational studies. … The comparative balance of
benefits and harms for dalteparin therapy versus
placebo or control was … Harms were not assessed in these trials or observational studies.
Key Question 7.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_disposition-comments.pdf
April 18, 2013 - i am just waiting to see how you deduce the no active
treatment harms. and even how you define it since … the
burden of migraine on qol, economics etc are certainly
harms that are not benefited by no active … Events in Migraine Trials of
the International Headache
Society86 when examining
the potential harms … Long-term harms can be detected at years of
followup. … Based on these
known adverse events the conclusion that beta
blockers are without bothersome harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/monitoring-programs-rapid-research.pdf
April 01, 2025 - Future research is needed to assess the effectiveness of relevant
interventions and unintended harms … How could supply chain disruption monitoring programs
prevent or mitigate harms? … How could supply chain disruption monitoring programs prevent or mitigate harms?
2. … How Could Supply Chain
Disruption Monitoring Programs Prevent or Mitigate Harms? … As there are currently no studies assessing
the benefits and potential harms of implementing supply
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-apps-a-e-surveillance-report-2-final_0_0.pdf
March 01, 2022 - The systematic review synthesizes evidence on the benefits and harms of plant-based
compounds (PBCs … Comparable THC to
CBD Ratio Benefits
and Harms
Benefits: small improvements in
pain severity and … Extracted Whole-
Plant High THC to
CBD Ratio Benefits
and Harms
Benefits: insufficient evidence … Tables 3 and 4 summarize benefits and harms of
cannabinoids. … We do not anticipate excluding
observational studies assessing harms.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/ehc-research-gaps-telehealth.pdf
April 01, 2023 - by identifying
characteristics of telehealth delivery, patient
populations, settings, benefits and harms … need agreement on common outcomes and
goals for P-P telehealth interventions so
interventions and harms … coercive control,
self-efficacy, post-traumatic stress disorder, and
safety behaviors; the evidence on harms … to understand the impact of telehealth on
patient engagement, access to care, health equity,
and harms
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/incident-user-design_research.pdf
May 01, 2012 - because the
celecoxib users would be more likely to be incident users at higher risk of any early harms … episodically (e.g., cycles of chemotherapy) and they
wish to capture the totality of benefits and harms … incident users during 1999 through 2001
may have had past episodes of naproxen use and survived any harms … Physicians’ Health Study was a randomized controlled trial designed to evaluate the
benefits and harms … A related point is that data sources may include too few events—benefits or harms—even if
they include
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/venous-ulcers-treatment_research-protocol.pdf
September 13, 2012 - For patients with chronic venous leg ulcers, what are the benefits and harms of surgical
procedures … For patients with chronic venous leg ulcers, what are the comparative benefits and harms of
different … Harms for topical antibiotics contained in dressings (KQ 1)
a. … Harms for systemic antibiotics (KQ 2)
a. Allergic and hypersensitivity reactions
b. … Harms for surgical interventions (KQ3)
a. Surgical site infection
b. Bleeding
c.
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/nephropathy-contrast-induced_research-protocol.pdf
October 01, 2013 - KQ 3: What are the comparative benefits and harms of different contrast media in patients
receiving … How do
benefits or harms differ by the dose of contrast medium (i.e., by volume of dose
and number … How do benefits or harms of contrast media differ according to the type of
preventive strategy used? … KQ 4: What are the comparative benefits and harms of different contrast media in patients
receiving … How do benefits or harms of contrast media differ according to the type of
preventive strategy used?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/high-cholestorol-medicines-update_executive.pdf
February 01, 2014 - Included adherence and harms outcomes—adherence, serious adverse events (as reported by investigators … Included FDA reports (SAE and harms only).
Excluded studies with other observational designs. … with hyperlipidemia, and most
were designed to evaluate effects on lipid measures and
short-term harms … Additional studies evaluating long-term clinical
benefits and harms are needed to better inform clinical … Systematic review:
comparative effectiveness and harms of combination therapy
and monotherapy for
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rtc-design-principles_research.pdf
January 01, 2009 - patients to the new test
strategy or current best practice provide ideal evidence of the net benefits or harms … McCaffery among these White Papers and in
Medical Decision Making.5)
The incremental benefits and harms … When do we need long-term RCTs to assess trade-offs between the benefits
and harms of a new test? … the
feasibility of a long-term RCT, both practical and ethical, to quantify all the benefits
and harms … Decision-analytic modeling to
evaluate benefits and harms of
medical tests: uses and limitations.
-
effectivehealthcare.ahrq.gov/sites/default/files/product/pdf/ems-911-workforce-protocol.pdf
January 01, 2015 - What are the characteristics and reported effectiveness (i.e., benefits and harms)
in studies of EMS … What is the reported effectiveness (i.e. benefits and harms) in studies of
EMS/911 workforce practices … What are the characteristics and reported effectiveness (i.e., benefits and harms)
in studies of EMS … What is the reported effectiveness (i.e., benefits and harms) in studies of
EMS/911 workforce practices
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/TND_0274_03-10-2008.pdf
January 01, 2008 - a clinical effectiveness review
that evaluates expanded indications and includes health outcomes, harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/episodic-migraine-surveillance-report-1.pdf
June 01, 2022 - The original 2020 report examined the evidence
on the comparative effectiveness and harms of opioids … harms, infections, cardiovascular events, cognitive harms, and psychological
harms (e.g., depression … gastrointestinal-related harms,
cardiovascular-related harms, kidney-related harms, falls, fractures … , motor vehicle accidents,
endocrinological harms, infections, cognitive harms, and psychological harms … Misuse, opioid use disorder, overdose and other harms
KQ2.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-250-cannabis-surveillance-report-3_0.pdf
May 01, 2022 - The systematic review synthesizes evidence on the benefits and harms of plant-based
compounds (PBCs … Comparable THC to
CBD Ratio Benefits
and Harms
Benefits: small improvements in
pain severity and … Extracted Whole-
Plant High THC to
CBD Ratio Benefits
and Harms
Benefits: insufficient evidence … Tables 3 and 4 summarize benefits and harms of
cannabinoids, based on evidence reviewed to date. … We do not anticipate excluding
observational studies assessing harms.
-
effectivehealthcare.ahrq.gov/system/files/docs/headaches-pregnancy-topic-brief.pdf
January 01, 2019 - What are the harms, effectiveness, and comparative effectiveness and harms of treatments
for headache … None of these reported on
effectiveness, all outcomes were maternal and fetal safety and harms. … KQ2 (Harms of migraine therapy) is feasible; effectiveness is not feasible. … Medications in pregnancy may cause
fetal and infant harms.
2b. … Incorporates issues around both clinical benefits and
potential clinical harms
Yes
2e.
-
effectivehealthcare.ahrq.gov/sites/default/files/topic-refinement.ppt
March 01, 2010 - Harms need to be considered in order to determine the balance of benefits to harms. … We cannot consider only the efficacy of these agents but also need to consider their harms. … Outcome — What are the benefits and harms being evaluated? … What are the benefits and harms being evaluated? T is for timing. What is the followup time? … Given the paucity of harms data, could harms data from patients without cystic fibrosis be used to inform
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/kidney-stones-protocol.pdf
September 24, 2024 - of the Review
This systematic review will assess the effectiveness, comparative effectiveness, and harms … Do harms vary by blood or urine chemistry or genetic testing performed as followup after
treatment is … KQ 4: What are the comparative harms of surveillance imaging strategies in nonpregnant
children and … Do harms vary with preventive treatment?
b. Do harms vary by timing of imaging? … Other subgroups of interest include those
defined by age (to examine whether the benefits and harms
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/mhs-IV-rapid-response-patient-family-engagement.pdf
October 01, 2023 - of patients and/or family
members in reporting and/or reducing patient safety events and associated harms … What is the frequency and severity of harms addressed by the patient and family
engagement PSPs? … for the patient and family engagement PSPs that have been
used to prevent, report or mitigate the harms … We answered Review Questions 1 and 2 by focusing on the harms and patient
safety measures or indicators … What Are the Frequency and
Severity of Harms Addressed by the Patient and Family
Engagement PSPs?
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cancer-anemia-update_disposition-comments.pdf
April 25, 2013 - agents across diverse populations over more than a decade, the
potential mechanism of action for the harms … not inform the
mechanism of action or clearly identify which patients will
experience benefits or harms … The authors may consider the following regarding this statement:
1)- state what the specific harms are … There is a plausible explanation of harms
based on thromboembolic complications. … A discussion of REMS as it applies to benefits
and harms is beyond the scope of this report.